• [(68)Ga]Ga-FAPI-46 False-Positive Uptake After Chemotherapy in Nonseminomatous Germ Cell Tumor Metastatic Lesions
• A Case of Non-Seminomatous Germ Cell Tumor Complicated by Tumor Thrombus in an Active Duty Soldier
• A Challenging Case of Heart Displacement by a Large Mediastinal Germ Cell Tumor
• A Nonseminomatous Germ Cell Tumor Presenting as a Mixed Cryoglobulinemic Vasculitis
• A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancer
• A Primary Spinal Nongerminomatous Germ Cell Tumor With Multiple Intracranial Metastases in a Toddler
• A rare case of a male primary mediastinal choriocarcinoma accompanying lung metastasis
• A rare case of brain metastatic of primary mediastinal yolk sac tumor
• Analysis of prognostic factors and establishment of prognostic model for primary mediastinal germ cell tumors: a case controlled study
• Association of the minimal cyclophosphamide equivalent dose and outcome of microdissection testicular sperm extraction in patients with persistent azoospermia after chemotherapy
• Case of testicular nonseminomatous germ cell tumor cancer soft tissue seeding after inguinal orchiectomy
• CNS non-germinomatous germ cell tumor (NGGCT): Lessons from the recent past
• Comparison between free β subunit of human chorionic gonadotropin (hCG) and total hCG assays in adults with testicular cancer
• Comparison of laparoscopic, robotic, and open retroperitoneal lymph node dissection for non-seminomatous germ cell tumor: a single-center retrospective cohort study
• Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor
• Consolidative radiation in partial responders/unresectable/recurrent disease after first-line/salvage chemotherapy in poor-risk nonseminomatous germ cell tumor prolongs survival: A new paradigm?
• Corrigendum to "Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?": [Modern Pathology 34 (2021) 834-841]
• CT Rendering and Radiomic Analysis in Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer to Anticipate Difficulties for Young Surgeons
• Diagnostic and Imaging Features of a Non-seminomatous Germ Cell Tumor of the Testis: A Case Report and Review of the Literature
• Diagnostic Value of the Texture Analysis Parameters of Retroperitoneal Residual Masses on Computed Tomographic Scan after Chemotherapy in Non-Seminomatous Germ Cell Tumors
• Discordance of retroperitoneal and thoracic histologic findings in patients with metastatic germ cell tumors at postchemotherapy residual tumor resection
• Endoscopic aqueductal membrane fenestration was effective for intractable hydrocephalus after removal of a nongerminomatous germ cell tumor exhibiting growing teratoma syndrome: a case report
• Evaluation and Management of Testicular Cancer After Late Relapse
• Exceedingly Rare Bilateral Synchronous Germ Cell Testicular Tumors With Different Histopathological Features
• Expression of CD44 is associated with aggressiveness in seminomas
• Extragonadal germ cell tumors: A clinicopathologic study with emphasis on molecular features, clinical outcomes and associated secondary malignancies
• Gastrointestinal bleeding caused by metastatic testicular choriocarcinoma: a case report and literature review
• Generalized Lymphatic Anomaly as a Differential Diagnosis of Lytic Lesions
• Germ Cell Seminoma
• Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer
• Growing Teratoma Syndrome-A Clinicoradiological Series
• High-dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience
• How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence
• How to do an open midline extraperitoneal bilateral retroperitoneal lymph node dissection for non-seminomatous germ cell tumour
• Improved survival of poor-risk non-seminomatous germ cell tumor patients: real-world data from a single institute in Japan
• Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
• Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours
• Isochromosome 12p Formation Regulates Vitamin D Metabolism in Testicular Cancer
• Kidney Autotransplantation in the Management of Residual Retroperitoneal Mass in a Germ Cell Tumor
• Laparoscopic retroperitoneal lymph-node dissection in metastatic nonseminomatous germ-cell tumors
• Malignant germ cell tumors in men aged 50 years and over are associated with adverse pathologic features and higher stage at presentation
• Malignant testicular tumors in children: overview on 10 years of Saudi Cancer Registry
• Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors
• Management of testicular tumours in patients with undescended testes- a challenging but rewarding task: experience from a tertiary care cancer centre in India
• Mediastinal Presentation of Testicular Embryonal Carcinoma
• Mimicker of Osteoblastic Skeletal Metastasis on 18 F-FDG PET/CT Scan in a Case of Primary Mediastinal Germ Cell Tumor
• Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment
• Moving the Needle in Early Stage Testicular Germ Cell Tumor Management: The MAGESTIC Trial
• Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome
• Neuroimaging features of non-germinomatous germ cell tumour with subtle pineal gland involvement in a child
• Nonseminomatous Testicular Tumors
• Onco-TESE (Testicular Sperm Extraction): Insights from a Tertiary Center and Comprehensive Literature Analysis
• Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors
• Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors
• Overexpression of SerpinB9 in non-seminomatous germ cell tumors
• Partial Sacral Resection for the Treatment of Isolated Testicular Tumor Metastasis
• Peri-treatment adverse events of primary mediastinal non-seminomatous germ cell tumors
• Peripubertal Presentation of Metastatic Testicular Mixed, Nonseminomatous Germ Cell Tumor
• Postchemotherapy Retroperitoneal Lumpectomy in Patients with Nonseminoma Testicular Cancer: A Nationwide Study
• Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy
• Postchemotherapy robotic retroperitoneal lymph node dissection for non-seminomatous germ cell tumors in the lateral decubitus position: oncological and functional outcomes
• Primary gastric choriocarcinoma: a rare and aggressive gastrointestinal malignancy
• Primary mediastinal choriocarcinoma in an 18-year-old male with pulmonary and brain metastasis: A case report
• Primary Mediastinal Germ Cell Tumors (PMGCT): A Real-world Analysis From A Tertiary Cancer Care Center in India
• Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
• Primary retroperitoneal mature teratoma in a young female: Case report
• Prolonged survival after thoracic metastasectomy in patients with nonseminomatous testicular cancer
• Pure testicular choriocarcinoma with gastrointestinal metastasis and paraneoplastic symptoms: a case report
• Quality of life assessment in testicular non-seminomatous germ cell tumour survivors
• Re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In pre
• Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2
• Resection of Residual Masses After Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumors in Adolescents and Adults
• Retroperitoneal tumour resection in fifteen consecutive cases: Single centre experience
• Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospectiv
• Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study
• Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance
• Severe thyrotoxicosis as initial presentation of gastric choriocarcinoma: a case report
• Small Testicular Masses: Contemporary Diagnostic and Treatment Strategies, Future Directions, and Knowledge Gaps
• Subsets of preoperative sex hormones in testicular germ cell cancer: a retrospective multicenter study
• Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID-19 infection
• Successful treatment of primary mediastinal choriocarcinoma with lung metastasis in a 13-year-old male
• Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor
• Survival outcomes of postchemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: A retrospective cohort study from a single tertiary center in South India
• TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis
• Testicular Germ Cell Tumors with Venous Tumor Thrombus: Prevalence, Presentation, and Management
• Testicular Radiomics To Predict Pathology At Time of Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumor
• The Status of Spermatogenesis in Germ Cell Tumor Bearing Testis and Its Association with Metastatic Disease
• The Subtype Identity of Testicular Cancer Cells Determines Their Immunostimulatory Activity in a Coculture Model
• Three Cases of Bilateral Metachronous Testicular Tumors
• Treatment Outcome of Response-Based Radiation Therapy in Children and Adolescents With Central Nervous System Nongerminomatous Germ Cell Tumors: Results of a Prospective Study
• Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review
• Tumor Lysis Syndrome in a Patient with Germ Cell Tumor : A Case Report
• Tumor Marker Decline in Predicting Treatment Outcome among Poor-Risk Testicular Germ Cell Tumors-A Tertiary Cancer Center Data
• Ultrasonic misdiagnosis of giant pediatric testicular yolk sac tumor: A case report and literature review
• Unusual Presentation of Embryonal Carcinoma of the Testis: A Case Report
• Updating germ cell tumour pathogenesis - the ability of seminomas for FOXA2-driven extra-embryonic differentiation
• Utility of frozen section in pediatric and adolescent malignant ovarian nonseminomatous germ cell tumors: A report from the children's oncology group
• Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
• Vision Loss as Presenting Symptom in Testicular Cancer: A Morbid Case Report
• Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma?